Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alpha Tau Medical Ltd. - Warrant (NQ: DRTSW )

0.2400 +0.0347 (+16.90%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,000
Open 0.2499
Bid (Size) 0.1977 (14)
Ask (Size) 0.2400 (118)
Prev. Close 0.2053
Today's Range 0.2398 - 0.2499
52wk Range 0.1400 - 0.4002
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Alpha Tau Medical Ltd.
Via GlobeNewswire

Performance

YTD
+5.54%
+5.54%
1 Month
+20.00%
+20.00%
3 Month
-9.43%
-9.43%
6 Month
N/A
N/A
1 Year
-31.43%
-31.43%

More News

Read More
Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network Open
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau Announces Health Canada Authorization for Alpha DaRT Clinical Trial for the Treatment of Liver Metastases
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau to Present at Upcoming November Investor Conferences
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation Oncology
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.